By contrast, levels of SFRP1 and SFRP2 methylation were consistently elevated in lesions throughout the entire bowel, indicating that those genes are methylated, irrespective of tumor location or the molecular subtype of the tumor. The gene discussed is SFRP2; the disease is neoplasm.